128 related articles for article (PubMed ID: 38478366)
1. Silymarin (Milk Thistle) Treatment of Adults With Gambling Disorder: A Double-Blind, Placebo-Controlled Trial.
Grant JE; Driessens C; Chamberlain SR
Clin Neuropharmacol; 2024 Mar-Apr 01; 47(2):54-58. PubMed ID: 38478366
[TBL] [Abstract][Full Text] [Related]
2. Milk Thistle Treatment for Children and Adults with Trichotillomania: A Double-Blind, Placebo-Controlled, Crossover Negative Study.
Grant JE; Redden SA; Chamberlain SR
J Clin Psychopharmacol; 2019; 39(2):129-134. PubMed ID: 30694881
[TBL] [Abstract][Full Text] [Related]
3. Escitalopram treatment of pathological gambling with co-occurring anxiety: an open-label pilot study with double-blind discontinuation.
Grant JE; Potenza MN
Int Clin Psychopharmacol; 2006 Jul; 21(4):203-9. PubMed ID: 16687991
[TBL] [Abstract][Full Text] [Related]
4. A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges.
Grant JE; Kim SW; Hartman BK
J Clin Psychiatry; 2008 May; 69(5):783-9. PubMed ID: 18384246
[TBL] [Abstract][Full Text] [Related]
5. A single-blind study of 'as-needed' ecopipam for gambling disorder.
Grant JE; Odlaug BL; Black DW; Fong T; Davtian M; Chipkin R; Kim SW
Ann Clin Psychiatry; 2014 Aug; 26(3):179-86. PubMed ID: 25166480
[TBL] [Abstract][Full Text] [Related]
6. Olanzapine in the treatment of pathological gambling: a negative randomized placebo-controlled trial.
McElroy SL; Nelson EB; Welge JA; Kaehler L; Keck PE
J Clin Psychiatry; 2008 Mar; 69(3):433-40. PubMed ID: 18251624
[TBL] [Abstract][Full Text] [Related]
7. A Randomized Trial of Silymarin for the Treatment of Nonalcoholic Steatohepatitis.
Wah Kheong C; Nik Mustapha NR; Mahadeva S
Clin Gastroenterol Hepatol; 2017 Dec; 15(12):1940-1949.e8. PubMed ID: 28419855
[TBL] [Abstract][Full Text] [Related]
8. A Randomised, Double-Blind, Placebo-Controlled Trial of As-Needed Naltrexone in the Treatment of Pathological Gambling.
Kovanen L; Basnet S; Castrén S; Pankakoski M; Saarikoski ST; Partonen T; Alho H; Lahti T
Eur Addict Res; 2016; 22(2):70-9. PubMed ID: 26339899
[TBL] [Abstract][Full Text] [Related]
9. Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis C unsuccessfully treated with interferon therapy: a randomized controlled trial.
Fried MW; Navarro VJ; Afdhal N; Belle SH; Wahed AS; Hawke RL; Doo E; Meyers CM; Reddy KR;
JAMA; 2012 Jul; 308(3):274-82. PubMed ID: 22797645
[TBL] [Abstract][Full Text] [Related]
10. Predicting response to opiate antagonists and placebo in the treatment of pathological gambling.
Grant JE; Kim SW; Hollander E; Potenza MN
Psychopharmacology (Berl); 2008 Nov; 200(4):521-7. PubMed ID: 18581096
[TBL] [Abstract][Full Text] [Related]
11. A double-blind, placebo-controlled trial of topiramate for pathological gambling.
Berlin HA; Braun A; Simeon D; Koran LM; Potenza MN; McElroy SL; Fong T; Pallanti S; Hollander E
World J Biol Psychiatry; 2013 Mar; 14(2):121-8. PubMed ID: 21486110
[TBL] [Abstract][Full Text] [Related]
12. Bupropion in the treatment of pathological gambling: a randomized, double-blind, placebo-controlled, flexible-dose study.
Black DW; Arndt S; Coryell WH; Argo T; Forbush KT; Shaw MC; Perry P; Allen J
J Clin Psychopharmacol; 2007 Apr; 27(2):143-50. PubMed ID: 17414236
[TBL] [Abstract][Full Text] [Related]
13. Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: A randomized, double-blind, placebo controlled trial.
Navarro VJ; Belle SH; D'Amato M; Adfhal N; Brunt EM; Fried MW; Reddy KR; Wahed AS; Harrison S;
PLoS One; 2019; 14(9):e0221683. PubMed ID: 31536511
[TBL] [Abstract][Full Text] [Related]
14. N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study.
Grant JE; Kim SW; Odlaug BL
Biol Psychiatry; 2007 Sep; 62(6):652-7. PubMed ID: 17445781
[TBL] [Abstract][Full Text] [Related]
15. A randomized, placebo-controlled trial of N-acetylcysteine plus imaginal desensitization for nicotine-dependent pathological gamblers.
Grant JE; Odlaug BL; Chamberlain SR; Potenza MN; Schreiber LR; Donahue CB; Kim SW
J Clin Psychiatry; 2014 Jan; 75(1):39-45. PubMed ID: 24345329
[TBL] [Abstract][Full Text] [Related]
16. Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling.
Grant JE; Potenza MN; Hollander E; Cunningham-Williams R; Nurminen T; Smits G; Kallio A
Am J Psychiatry; 2006 Feb; 163(2):303-12. PubMed ID: 16449486
[TBL] [Abstract][Full Text] [Related]
17. Double-blind, placebo-controlled, pilot trial of paliperidone augmentation in serotonin reuptake inhibitor-resistant obsessive-compulsive disorder.
Storch EA; Goddard AW; Grant JE; De Nadai AS; Goodman WK; Mutch PJ; Medlock C; Odlaug B; McDougle CJ; Murphy TK
J Clin Psychiatry; 2013 Jun; 74(6):e527-32. PubMed ID: 23842022
[TBL] [Abstract][Full Text] [Related]
18. Effects of Silybum marianum (L.) Gaertn. (silymarin) extract supplementation on antioxidant status and hs-CRP in patients with type 2 diabetes mellitus: a randomized, triple-blind, placebo-controlled clinical trial.
Ebrahimpour Koujan S; Gargari BP; Mobasseri M; Valizadeh H; Asghari-Jafarabadi M
Phytomedicine; 2015 Feb; 22(2):290-6. PubMed ID: 25765835
[TBL] [Abstract][Full Text] [Related]
19. Randomized, Double-Blind, Placebo-Controlled Trial of N-Acetylcysteine Augmentation for Treatment-Resistant Obsessive-Compulsive Disorder.
Costa DLC; Diniz JB; Requena G; Joaquim MA; Pittenger C; Bloch MH; Miguel EC; Shavitt RG
J Clin Psychiatry; 2017 Jul; 78(7):e766-e773. PubMed ID: 28617566
[TBL] [Abstract][Full Text] [Related]
20. Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver.
Ferenci P; Dragosics B; Dittrich H; Frank H; Benda L; Lochs H; Meryn S; Base W; Schneider B
J Hepatol; 1989 Jul; 9(1):105-13. PubMed ID: 2671116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
